ChiRhoStim® (Synthetic Human Secretin)
Facilitation of ERCP cannulation & identification of Ampulla of Vater
Key Facts
About ChiRhoClin
Founded in 1991 by Dr. Edward D. Purich, ChiRhoClin is a specialized pharmaceutical company dedicated to orphan theranostics for gastrointestinal and pancreatic disorders. Its core achievement is the FDA approval and commercialization of ChiRhoStim® (Synthetic Human Secretin), used in diagnostic pancreatic function tests and to facilitate endoscopic retrograde cholangiopancreatography (ERCP). The company maintains a research-oriented culture, supports academic research through grant programs, and collaborates with major medical institutions on ongoing clinical studies in pancreatic cancer and pancreatitis.
View full company profileAbout ChiRhoClin
Founded in 1991 by Dr. Edward D. Purich, ChiRhoClin is a specialized pharmaceutical company dedicated to orphan theranostics for gastrointestinal and pancreatic disorders. Its core achievement is the FDA approval and commercialization of ChiRhoStim® (Synthetic Human Secretin), used in diagnostic pancreatic function tests and to facilitate endoscopic retrograde cholangiopancreatography (ERCP). The company maintains a research-oriented culture, supports academic research through grant programs, and collaborates with major medical institutions on ongoing clinical studies in pancreatic cancer and pancreatitis.
View full company profile